Latest Insider Transactions at Karuna Therapeutics, Inc. (KRTX)
This section provides a real-time view of insider transactions for Karuna Therapeutics, Inc. (KRTX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Karuna Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Karuna Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,264
+33.33%
|
-
|
|
Jan 08
2021
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.67%
|
-
|
|
Jan 08
2021
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
1,756
+33.33%
|
-
|
|
Jan 08
2021
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.67%
|
-
|
|
Dec 29
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,000
+24.57%
|
$72,000
$9.2 P/Share
|
|
Dec 14
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,714
-100.0%
|
$525,688
$92.64 P/Share
|
|
Dec 14
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,714
+50.0%
|
$11,428
$2.92 P/Share
|
|
Dec 14
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
12,500
+21.55%
|
$25,000
$2.92 P/Share
|
|
Dec 10
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-5.16%
|
$470,000
$94.82 P/Share
|
|
Dec 10
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+4.87%
|
$40,000
$8.24 P/Share
|
|
Nov 12
2020
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
1,264
+50.0%
|
-
|
|
Nov 12
2020
|
Arch Venture Partners Ix, LLC > 10% Shareholder |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.46%
|
-
|
|
Nov 12
2020
|
Robert Nelsen Director |
BUY
Other acquisition or disposition
|
Direct |
1,757
+50.0%
|
-
|
|
Nov 12
2020
|
Robert Nelsen Director |
SELL
Other acquisition or disposition
|
Indirect |
150,000
-4.46%
|
-
|
|
Nov 12
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$480,000
$96.84 P/Share
|
|
Nov 12
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.92 P/Share
|
|
Nov 12
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,334
-20.16%
|
$833,400
$100.0 P/Share
|
|
Nov 12
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,334
+16.78%
|
$75,006
$9.2 P/Share
|
|
Nov 11
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
8,333
-20.16%
|
$833,300
$100.01 P/Share
|
|
Nov 11
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
8,333
+16.78%
|
$74,997
$9.2 P/Share
|
|
Nov 10
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
13,333
-16.51%
|
$1,373,299
$103.8 P/Share
|
|
Nov 10
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
13,333
+14.01%
|
$106,664
$8.24 P/Share
|
|
Nov 10
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
118
-2.31%
|
$12,154
$103.48 P/Share
|
|
Nov 10
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
118
+2.25%
|
$1,062
$9.2 P/Share
|
|
Nov 09
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
9,318
-41.2%
|
$987,708
$106.64 P/Share
|
|
Nov 09
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
9,318
+27.68%
|
$83,862
$9.2 P/Share
|
|
Nov 06
2020
|
Troy A. Ignelzi Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
564
-10.14%
|
$60,912
$108.15 P/Share
|
|
Nov 06
2020
|
Troy A. Ignelzi Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
564
+9.2%
|
$5,076
$9.2 P/Share
|
|
Nov 03
2020
|
Atul Pande |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$425,000
$85.0 P/Share
|
|
Nov 03
2020
|
Atul Pande |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$10,000
$2.92 P/Share
|
|
Oct 12
2020
|
Andrew Craig Miller President of R&D |
SELL
Open market or private sale
|
Direct |
5,000
-13.16%
|
$390,000
$78.67 P/Share
|
|
Oct 12
2020
|
Andrew Craig Miller President of R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+11.63%
|
$35,000
$7.27 P/Share
|